Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP615564.RAlSg2r0tQlt_YZIe4lTxdcx-SdiLYUbI2Q_CZ4e4sheQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP615564.RAlSg2r0tQlt_YZIe4lTxdcx-SdiLYUbI2Q_CZ4e4sheQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP615564.RAlSg2r0tQlt_YZIe4lTxdcx-SdiLYUbI2Q_CZ4e4sheQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP615564.RAlSg2r0tQlt_YZIe4lTxdcx-SdiLYUbI2Q_CZ4e4sheQ130_provenance.
- NP615564.RAlSg2r0tQlt_YZIe4lTxdcx-SdiLYUbI2Q_CZ4e4sheQ130_assertion description "[MDR1 RNA levels were usually elevated in untreated, intrinsically drug-resistant tumors, including those derived from the colon, kidney, adrenal gland, liver, and pancreas, as well as in carcinoid tumors, chronic myelogenous leukemia in blast crisis, and cell lines of non-small cell carcinoma of the lung (NSCLC) with neuroendocrine properties.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615564.RAlSg2r0tQlt_YZIe4lTxdcx-SdiLYUbI2Q_CZ4e4sheQ130_provenance.
- NP615564.RAlSg2r0tQlt_YZIe4lTxdcx-SdiLYUbI2Q_CZ4e4sheQ130_assertion evidence source_evidence_literature NP615564.RAlSg2r0tQlt_YZIe4lTxdcx-SdiLYUbI2Q_CZ4e4sheQ130_provenance.
- NP615564.RAlSg2r0tQlt_YZIe4lTxdcx-SdiLYUbI2Q_CZ4e4sheQ130_assertion SIO_000772 2562856 NP615564.RAlSg2r0tQlt_YZIe4lTxdcx-SdiLYUbI2Q_CZ4e4sheQ130_provenance.
- NP615564.RAlSg2r0tQlt_YZIe4lTxdcx-SdiLYUbI2Q_CZ4e4sheQ130_assertion wasDerivedFrom befree-20140225 NP615564.RAlSg2r0tQlt_YZIe4lTxdcx-SdiLYUbI2Q_CZ4e4sheQ130_provenance.
- NP615564.RAlSg2r0tQlt_YZIe4lTxdcx-SdiLYUbI2Q_CZ4e4sheQ130_assertion wasGeneratedBy ECO_0000203 NP615564.RAlSg2r0tQlt_YZIe4lTxdcx-SdiLYUbI2Q_CZ4e4sheQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP615564.RAlSg2r0tQlt_YZIe4lTxdcx-SdiLYUbI2Q_CZ4e4sheQ130_provenance.